ANN ARBOR, Mich. — Touted for safety, ease and patient convenience, peripherally inserted central catheters have become many clinicians' go-to for IV delivery of antibiotics, nutrition, chemotherapy, and other medications.
But compared to other central venous catheters (CVCs), these commonly-used catheters (known as PICCs) more than double the risk of dangerous blood clots – especially among patients who are critically ill or who have cancer, according to a new University of Michigan Health System study published in The Lancet.